Objective-To investigate the relation between plasma concentrations of immunoreactive endothelin and haemodynamic variables before and after percutaneous transvenous balloon dilatation of the mitral valve.
Abstract
Objective-To investigate the relation between plasma concentrations of immunoreactive endothelin and haemodynamic variables before and after percutaneous transvenous balloon dilatation of the mitral valve.
Design-Prospective study. Setting-National cardiovascular centre.
Patients-25 patients with mitral stenosis and 26 healthy volunteers.
Main outcome measures-Plasma concentrations of immunoreactive endothelin were measured in the pulmonary artery, left atrium, ascending aorta, and femoral vein before and after balloon dilatation of the mitral valve.
Results-Peripheral venous concentrations (mean (SD)) of endothelin were higher in the patients with mitral stenosis than in the healthy volunteers (176 (0-51) v 1-37 (0.45) pg/ml, p < 0.05) and they correlated with the mean left atrial pressure (r = 0 74, p < 0.01). Balloon dilatation of the mitral valve reduced the mean left atrial pressure without changing the mean right atrial pressure, systemic arterial pressure, heart rate, or cardiac index. Concentrations of plasma endothelin in the femoral vein increased from 1-76 (0-51) to 3*39 (2.46) (p < 0.01), 4-82 (2.34) (p < 0-001), and 2*43 (0.52) pg/ml (p < 0.05) at 15 and 30 minutes and 24 hours after the procedure. The concentration of endothelin in the pulmonary artery also increased from 1 85 (0.85) to 4-32 (1.58) pg/ml (p < 0.01) 30 minutes after the dilatation, whereas there were no appreciable changes in endothelin concentration in the left atrium or ascending aorta.
Conclusions-Plasma endothelin concentrations were higher in patients with mitral stenosis than Mitral stenosis was diagnosed by physical examination and echocardiography. Diuretics and digitalis were discontinued at least 24 hours before valve dilatation and all other medications, including sleeping pills and indigestion tablets were stopped at least 12 hours before the study. No patients had essential hypertension, ischaemic heart disease, or renal failure. In 17 patients the mitral valve was dilated with an Inoue balloon catheter by the transseptal Brockenbrough method. '7 Haemodynamic variables including the pressures in the right atrium, right ventricle, pulmonary artery, left ventricle, left atrium, and ascending aorta, as well as the cardiac index were measured before and 30 minutes after valve dilatation. Blood samples were collected from the femoral vein, the pulmonary artery, left atrium and ascending aorta through a catheter and placed into ice-chilled tubes containing ethylenediamine tetra acetic acid (1 mg/ml) and aprotinin (500 kallikrein inactivation units/ml) before and, 15 and 30 minutes and 24 hours after balloon dilatation of the mitral valve.
The other eight patients underwent only diagnostic cardiac catheterisation and their femoral venous blood samples were obtained through a catheter before and immediately after the catheterisation to examine the effects of the catheterisation on the plasma concentration of immunoreactive endothelin.
We also collected blood samples through an antecubital vein from 26 apparently healthy volunteers (11 men and 15 women; mean (SD) age, 54 (8) years) without evidence of organic heart disease, essential hypertension, or renal failure.
MEASUREMENT OF PLASMA ENDOTHELIN CONCENTRATION
Plasma concentrations of immunoreactive endothelin were measured by a sensitive radioimmunoassay." In brief, a 4 ml volume of plasma was acidified with 1 ml of 0 5 N solution of hydrochloric acid and applied to a C8 octyl cartridge (Amersham, UK) which had been treated with 5 ml of methanol and subsequently with 20 ml of distilled water. After washing with 20 ml of 0-1% trifluoroacetic acid, adsorbed materials were eluted from the cartridge with 3-5 ml of 60% acetonitrile/0 1% trifluoroacetic acid, dried under a stream of nitrogen and reconstituted in 0 4 ml of radioimmunoassay buffer.
Standard endothelin-1 (Peptide Institute, 1) . Similarly, the pulmonary arterial plasma immunoreactive endothelin concentration also increased from 1-85 (0-85) to 4X32
(1 58) pg/ml (p < 0.01) at 30 minutes after balloon dilatation whereas there were no appreciable changes in the plasma immunoreactive endothelin concentration in the left atrium or ascending aorta (table 2) . Diagnostic cardiac catheterisation did not affect femoral venous plasma immunoreactive endothelin concentrations in eight patients with mitral stenosis (1-78 (0-45) v 1-81 (0 56) pg/ml, NS). Before the procedure femoral venous plasma immunoreactive endothelin concentrations ranged from 0'85 to 2-43 pg/ml (mean 1 76 (0-51) pg/ml. Concentrations were slightly but significantly higher than those in blood from an antecubital vein in the healthy volunteers (1X37 (0 45) pg/ml, p < 005) (fig 2) . There were no significant differences in the concentrations of plasma immunoreactive endothelin in the femoral vein, pulmonary artery, left atrium, and ascending aorta. Figure 3 shows there was a positive correlation between the mean left atrial pressure and the femoral venous plasma immunoreactive endothelin concentration in the patients before balloon dilatation of the mitral valve (r = 0 74, p < 0 01). 
Discussion
We showed that peripheral venous concentrations of plasma immunoreactive endothelin in patients with symptomatic mitral stenosis were significantly higher than those in healthy volunteers. There was a positive correlation between the mean left atrial pressure and the concentration of endothelin in the femoral vein. These findings accord with the responded increase in plasma endothelin concentration in patients with congestive heart failure caused by various types of heart disease.7 In dogs with experimental congestive heart failure evoked by rapid ventricular pacing, the concentration of plasma endothelin in the femoral artery was increased and showed a positive correlation with the pulmonary capillary wedge pressure.9 The mechanism underlying this raised plasma endothelin concentration is uncertain. Plasma endothelin concentrations are increased in patients with pulmonary hypertension,619 so the pulmonary hypertension associated with mitral stenosis may be a stimulus. Endothelin is expressed not only in vascular endothelial cells but also in other tissues, including the lungs and heart,'21' and endothelin mRNA is widespread, indicating that the peptide may be synthesised in many tissues.'4'6 This evidence suggests that endothelin may be related to congestive heart failure caused by mitral stenosis, because in congestive heart failure there is precapillary pulmonary hypertension and inappropriate peripheral vasoconstriction. Endothelin may be another vasoactive substance involved in congestive heart failure-like the cathecholamines and angiotensin II. We found that percutaneous balloon dilatation of the mitral valve rapidly reduced left atrial pressure and caused a prompt increase in the plasma immunoreactive endothelin concentration in the femoral vein and pulmonary artery but not in the left atrium or ascending aorta. We showed that diagnostic cardiac catheterisation itself did not affect the plasma endothelin concentration in patients with mitral stenosis, suggesting that mechanical damage to vascular endothelial cells during the procedure was minimal. It is puzzling that balloon dilatation of the mitral valve increased the plasma endothelin concentration in venous blood but not in arterial blood. The relation between plasma endothelin concentration and the mean left atrial pressure before the procedure did not afford an explanation. There are several other possibilities.
First, haemodynamic or neurohormonal factors or both can stimulate the release of endothelin from vascular endothelial cells through the transient hypotension induced by the balloon inflation. There is a growing body of evidence suggesting that various factors can stimulate endothelin release from vascular endothelial cells, such as cardiogenic shock,6 systemic hypertension,202' adrenaline,' and angiotensin 11.22 In our previous but similar clinical study in patients with mitral stenosis, however, plasma concentrations of noradrenaline and adrenaline and renin activity levels were not affected by balloon dilatation of the mitral valve." Also systemic blood pressure and heart rate did not change between before and 30 minutes after balloon dilatation of the mitral valve in the present study. Thus these factors are unlikely to be involved in the increase in plasma endothelin concentration induced by balloon dilatation.
Secondly, enhanced pulmonary extraction of circulating endothelin may be attributable to balloon dilatation of the mitral valve, which transiently increases left atrial pressure. In the present study we showed that the left atrial:pulmonary arterial ratio of the plasma immunoreactive endothelin concentration decreased from the basal value of 0-98 to 0v42 after balloon dilatation, indicating that the procedure increased pulmonary extraction of endothelin. An increase in the functional pulmonary vascular bed caused by balloon dilatation of the mitral valve may be related to this enhanced pulmonary extraction of endothelin. There is evidence of considerable pulmonary extraction of endothelin.
Intravenously injected endothelin disappeared after passage through the lungs in rats, 23 and in healthy controls the endothelin concentration was higher in venous plasma than in arterial plasma; 24 The more likely explanation seems to be a mechanism associated with the cardiopulmonary baroreceptor reflex. In dogs cardiopulmonary baroreceptors at various cardiopulmonary sites including the left atrium are activated by distension and exert a tonic inhibitory effect on sympathetic vasomotor outflow.2526 Moreover, the concentration of endothelin in peripheral plasma increases in the standing position in humans, suggesting that secretion of endothelin from vascular endothelial cells may be regulated by changes in the extracellular fluid volume.27
However, this change could also be interpreted as an effect on the peripheral plasma endothelin concentration mediated by the cardiopulmonary baroreceptor reflex because the cardiopulmonary blood volume is reduced on standing and this inactivates the tonic inhibitory influence on the vasomotor centre. Congestive heart failure in humans and animals has been associated with the attenuation of cardiopulmonary baroreceptor control of circulation.28 29 Therefore, it is tempting to speculate that the increase in venous endothelin concentrations after balloon dilatation of the mitral valve may reflect a compensatory increase in the release of endothelin from the local vascular bed in response to the impaired cardiopulmonary baroreceptor reflex. Animal studies performed with and without denervation of the afferent vagal nerves would be required to verify the involvement of cardiopulmonary baroreceptor reflexes in the increase of plasma endothelin concentrations occurring in response to a reduction of left atrial pressure.
We found that plasma immunoreactive endothelin concentrations were higher in patients with mitral stenosis than in normal controls and that the increase was proportional to left atrial pressure; that after balloon dilatation of the mitral valve, there was an abrupt rise in femoral venous and pulmonary arterial concentrations of immunoreactive endothelin but no change in left atrial or aortic blood samples. These 
